nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Ethinyl Estradiol—osteoporosis	0.221	0.399	CbGbCtD
Levetiracetam—ABCC2—Conjugated Estrogens—osteoporosis	0.162	0.293	CbGbCtD
Levetiracetam—ABCB1—Ethinyl Estradiol—osteoporosis	0.0719	0.13	CbGbCtD
Levetiracetam—ABCB1—Conjugated Estrogens—osteoporosis	0.0528	0.0954	CbGbCtD
Levetiracetam—ABCB1—Estradiol—osteoporosis	0.0464	0.0837	CbGbCtD
Levetiracetam—SV2A—Uptake and actions of bacterial toxins—ANTXR2—osteoporosis	0.0269	0.352	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00988	0.129	CbGpPWpGaD
Levetiracetam—CACNA1B—Synaptic Vesicle Pathway—PARK7—osteoporosis	0.00747	0.0977	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00465	0.0608	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00158	0.0206	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PKM—osteoporosis	0.00116	0.0151	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SOST—osteoporosis	0.00116	0.0151	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PGLS—osteoporosis	0.0011	0.0144	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ANTXR2—osteoporosis	0.0011	0.0144	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.000969	0.0127	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000951	0.0124	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GSN—osteoporosis	0.000933	0.0122	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000907	0.0119	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LRP5—osteoporosis	0.000812	0.0106	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LRP6—osteoporosis	0.000777	0.0102	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000765	0.01	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LTF—osteoporosis	0.000746	0.00976	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RPL24—osteoporosis	0.000746	0.00976	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000743	0.00971	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000664	0.00868	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ACP5—osteoporosis	0.000647	0.00846	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TPI1—osteoporosis	0.000601	0.00786	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—ADCY5—osteoporosis	0.000587	0.00767	CbGpPWpGaD
Levetiracetam—SV2A—Disease—P4HB—osteoporosis	0.000566	0.00739	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GAPDH—osteoporosis	0.000555	0.00726	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NFATC1—osteoporosis	0.000527	0.0069	CbGpPWpGaD
Levetiracetam—SV2A—Disease—DKK1—osteoporosis	0.000523	0.00684	CbGpPWpGaD
Levetiracetam—SV2A—Disease—WNT1—osteoporosis	0.000504	0.00659	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGA—osteoporosis	0.00049	0.00641	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ENO1—osteoporosis	0.000437	0.00571	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PSMA2—osteoporosis	0.000431	0.00563	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PSMA5—osteoporosis	0.000431	0.00563	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000426	0.00558	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CALCA—osteoporosis	0.000401	0.00525	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KL—osteoporosis	0.000364	0.00477	CbGpPWpGaD
Levetiracetam—Abdominal pain—Raloxifene—osteoporosis	0.000364	0.000984	CcSEcCtD
Levetiracetam—Body temperature increased—Raloxifene—osteoporosis	0.000364	0.000984	CcSEcCtD
Levetiracetam—Vision blurred—Conjugated Estrogens—osteoporosis	0.000363	0.00098	CcSEcCtD
Levetiracetam—Body temperature increased—Ibandronate—osteoporosis	0.00036	0.000974	CcSEcCtD
Levetiracetam—Abdominal pain—Ibandronate—osteoporosis	0.00036	0.000974	CcSEcCtD
Levetiracetam—Confusional state—Pamidronate—osteoporosis	0.00036	0.000973	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000359	0.00469	CbGpPWpGaD
Levetiracetam—Vertigo—Zoledronate—osteoporosis	0.000359	0.000971	CcSEcCtD
Levetiracetam—Leukopenia—Zoledronate—osteoporosis	0.000358	0.000967	CcSEcCtD
Levetiracetam—Infection—Pamidronate—osteoporosis	0.000355	0.000959	CcSEcCtD
Levetiracetam—Rhinitis—Estradiol—osteoporosis	0.000355	0.000959	CcSEcCtD
Levetiracetam—Hepatitis—Estradiol—osteoporosis	0.000354	0.000956	CcSEcCtD
Levetiracetam—Abdominal pain—Calcitriol—osteoporosis	0.000353	0.000954	CcSEcCtD
Levetiracetam—Body temperature increased—Calcitriol—osteoporosis	0.000353	0.000954	CcSEcCtD
Levetiracetam—Pharyngitis—Estradiol—osteoporosis	0.000351	0.000949	CcSEcCtD
Levetiracetam—Hypersensitivity—Estropipate—osteoporosis	0.00035	0.000947	CcSEcCtD
Levetiracetam—Nervous system disorder—Pamidronate—osteoporosis	0.00035	0.000947	CcSEcCtD
Levetiracetam—Thrombocytopenia—Pamidronate—osteoporosis	0.000349	0.000945	CcSEcCtD
Levetiracetam—Vomiting—Etidronic acid—osteoporosis	0.000349	0.000944	CcSEcCtD
Levetiracetam—Cough—Zoledronate—osteoporosis	0.000349	0.000943	CcSEcCtD
Levetiracetam—Connective tissue disorder—Estradiol—osteoporosis	0.000348	0.00094	CcSEcCtD
Levetiracetam—Rash—Etidronic acid—osteoporosis	0.000346	0.000937	CcSEcCtD
Levetiracetam—Convulsion—Zoledronate—osteoporosis	0.000346	0.000936	CcSEcCtD
Levetiracetam—Dermatitis—Etidronic acid—osteoporosis	0.000346	0.000936	CcSEcCtD
Levetiracetam—Vertigo—Conjugated Estrogens—osteoporosis	0.000346	0.000935	CcSEcCtD
Levetiracetam—Hypersensitivity—Alendronate—osteoporosis	0.000345	0.000932	CcSEcCtD
Levetiracetam—Headache—Etidronic acid—osteoporosis	0.000344	0.00093	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000342	0.000925	CcSEcCtD
Levetiracetam—Asthenia—Estropipate—osteoporosis	0.000341	0.000922	CcSEcCtD
Levetiracetam—Anorexia—Pamidronate—osteoporosis	0.00034	0.00092	CcSEcCtD
Levetiracetam—Arthralgia—Zoledronate—osteoporosis	0.00034	0.00092	CcSEcCtD
Levetiracetam—Myalgia—Zoledronate—osteoporosis	0.00034	0.00092	CcSEcCtD
Levetiracetam—Chest pain—Zoledronate—osteoporosis	0.00034	0.00092	CcSEcCtD
Levetiracetam—Insomnia—Risedronate—osteoporosis	0.00034	0.000918	CcSEcCtD
Levetiracetam—Anxiety—Zoledronate—osteoporosis	0.000339	0.000917	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000338	0.000913	CcSEcCtD
Levetiracetam—Paraesthesia—Risedronate—osteoporosis	0.000337	0.000912	CcSEcCtD
Levetiracetam—Pruritus—Estropipate—osteoporosis	0.000336	0.000909	CcSEcCtD
Levetiracetam—Asthenia—Alendronate—osteoporosis	0.000336	0.000908	CcSEcCtD
Levetiracetam—Hypersensitivity—Ibandronate—osteoporosis	0.000336	0.000908	CcSEcCtD
Levetiracetam—Cough—Conjugated Estrogens—osteoporosis	0.000336	0.000908	CcSEcCtD
Levetiracetam—Erythema multiforme—Estradiol—osteoporosis	0.000334	0.000904	CcSEcCtD
Levetiracetam—Convulsion—Conjugated Estrogens—osteoporosis	0.000333	0.000901	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000332	0.000899	CcSEcCtD
Levetiracetam—Fatigue—Ethinyl Estradiol—osteoporosis	0.000332	0.000898	CcSEcCtD
Levetiracetam—Pruritus—Alendronate—osteoporosis	0.000331	0.000895	CcSEcCtD
Levetiracetam—Dyspepsia—Risedronate—osteoporosis	0.000331	0.000894	CcSEcCtD
Levetiracetam—Eye disorder—Estradiol—osteoporosis	0.000331	0.000894	CcSEcCtD
Levetiracetam—Constipation—Ethinyl Estradiol—osteoporosis	0.000329	0.000891	CcSEcCtD
Levetiracetam—Confusional state—Zoledronate—osteoporosis	0.000329	0.000889	CcSEcCtD
Levetiracetam—Hypersensitivity—Calcitriol—osteoporosis	0.000329	0.000889	CcSEcCtD
Levetiracetam—Myalgia—Conjugated Estrogens—osteoporosis	0.000327	0.000886	CcSEcCtD
Levetiracetam—Chest pain—Conjugated Estrogens—osteoporosis	0.000327	0.000886	CcSEcCtD
Levetiracetam—Arthralgia—Conjugated Estrogens—osteoporosis	0.000327	0.000886	CcSEcCtD
Levetiracetam—Asthenia—Ibandronate—osteoporosis	0.000327	0.000884	CcSEcCtD
Levetiracetam—Anxiety—Conjugated Estrogens—osteoporosis	0.000326	0.000883	CcSEcCtD
Levetiracetam—Nausea—Etidronic acid—osteoporosis	0.000326	0.000882	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000325	0.00088	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000325	0.00088	CcSEcCtD
Levetiracetam—Diarrhoea—Estropipate—osteoporosis	0.000325	0.000879	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Risedronate—osteoporosis	0.000324	0.000877	CcSEcCtD
Levetiracetam—Infection—Zoledronate—osteoporosis	0.000324	0.000876	CcSEcCtD
Levetiracetam—Fatigue—Risedronate—osteoporosis	0.000324	0.000876	CcSEcCtD
Levetiracetam—Insomnia—Pamidronate—osteoporosis	0.000323	0.000873	CcSEcCtD
Levetiracetam—Pruritus—Ibandronate—osteoporosis	0.000322	0.000872	CcSEcCtD
Levetiracetam—Pain—Risedronate—osteoporosis	0.000321	0.000868	CcSEcCtD
Levetiracetam—Constipation—Risedronate—osteoporosis	0.000321	0.000868	CcSEcCtD
Levetiracetam—Paraesthesia—Pamidronate—osteoporosis	0.000321	0.000867	CcSEcCtD
Levetiracetam—Diarrhoea—Alendronate—osteoporosis	0.00032	0.000866	CcSEcCtD
Levetiracetam—Asthenia—Calcitriol—osteoporosis	0.00032	0.000865	CcSEcCtD
Levetiracetam—Nervous system disorder—Zoledronate—osteoporosis	0.00032	0.000865	CcSEcCtD
Levetiracetam—Immune system disorder—Estradiol—osteoporosis	0.000319	0.000864	CcSEcCtD
Levetiracetam—Thrombocytopenia—Zoledronate—osteoporosis	0.000319	0.000863	CcSEcCtD
Levetiracetam—Mediastinal disorder—Estradiol—osteoporosis	0.000319	0.000862	CcSEcCtD
Levetiracetam—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000317	0.000858	CcSEcCtD
Levetiracetam—Somnolence—Pamidronate—osteoporosis	0.000317	0.000858	CcSEcCtD
Levetiracetam—Skin disorder—Zoledronate—osteoporosis	0.000317	0.000856	CcSEcCtD
Levetiracetam—Pruritus—Calcitriol—osteoporosis	0.000316	0.000853	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000315	0.000852	CcSEcCtD
Levetiracetam—Diarrhoea—Raloxifene—osteoporosis	0.000315	0.000852	CcSEcCtD
Levetiracetam—Dyspepsia—Pamidronate—osteoporosis	0.000314	0.00085	CcSEcCtD
Levetiracetam—Dizziness—Estropipate—osteoporosis	0.000314	0.00085	CcSEcCtD
Levetiracetam—Alopecia—Estradiol—osteoporosis	0.000313	0.000845	CcSEcCtD
Levetiracetam—Infection—Conjugated Estrogens—osteoporosis	0.000312	0.000844	CcSEcCtD
Levetiracetam—Diarrhoea—Ibandronate—osteoporosis	0.000312	0.000843	CcSEcCtD
Levetiracetam—Anorexia—Zoledronate—osteoporosis	0.000311	0.000841	CcSEcCtD
Levetiracetam—Decreased appetite—Pamidronate—osteoporosis	0.00031	0.000839	CcSEcCtD
Levetiracetam—Mental disorder—Estradiol—osteoporosis	0.00031	0.000838	CcSEcCtD
Levetiracetam—Dizziness—Alendronate—osteoporosis	0.000309	0.000837	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000308	0.000833	CcSEcCtD
Levetiracetam—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000308	0.000833	CcSEcCtD
Levetiracetam—Malnutrition—Estradiol—osteoporosis	0.000308	0.000833	CcSEcCtD
Levetiracetam—Fatigue—Pamidronate—osteoporosis	0.000308	0.000832	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Risedronate—osteoporosis	0.000307	0.00083	CcSEcCtD
Levetiracetam—Pain—Pamidronate—osteoporosis	0.000305	0.000826	CcSEcCtD
Levetiracetam—Constipation—Pamidronate—osteoporosis	0.000305	0.000826	CcSEcCtD
Levetiracetam—Diarrhoea—Calcitriol—osteoporosis	0.000305	0.000825	CcSEcCtD
Levetiracetam—Skin disorder—Conjugated Estrogens—osteoporosis	0.000305	0.000825	CcSEcCtD
Levetiracetam—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000304	0.000823	CcSEcCtD
Levetiracetam—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000304	0.000823	CcSEcCtD
Levetiracetam—Dizziness—Raloxifene—osteoporosis	0.000304	0.000823	CcSEcCtD
Levetiracetam—Tension—Estradiol—osteoporosis	0.000302	0.000817	CcSEcCtD
Levetiracetam—Vomiting—Estropipate—osteoporosis	0.000302	0.000817	CcSEcCtD
Levetiracetam—Dizziness—Ibandronate—osteoporosis	0.000301	0.000815	CcSEcCtD
Levetiracetam—Rash—Estropipate—osteoporosis	0.0003	0.00081	CcSEcCtD
Levetiracetam—Dermatitis—Estropipate—osteoporosis	0.000299	0.000809	CcSEcCtD
Levetiracetam—Anorexia—Conjugated Estrogens—osteoporosis	0.000299	0.000809	CcSEcCtD
Levetiracetam—Nervousness—Estradiol—osteoporosis	0.000299	0.000809	CcSEcCtD
Levetiracetam—Back pain—Estradiol—osteoporosis	0.000298	0.000805	CcSEcCtD
Levetiracetam—Headache—Estropipate—osteoporosis	0.000298	0.000805	CcSEcCtD
Levetiracetam—Vomiting—Alendronate—osteoporosis	0.000298	0.000805	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000297	0.000803	CcSEcCtD
Levetiracetam—Abdominal pain—Risedronate—osteoporosis	0.000297	0.000803	CcSEcCtD
Levetiracetam—Body temperature increased—Risedronate—osteoporosis	0.000297	0.000803	CcSEcCtD
Levetiracetam—Rash—Alendronate—osteoporosis	0.000295	0.000798	CcSEcCtD
Levetiracetam—Insomnia—Zoledronate—osteoporosis	0.000295	0.000798	CcSEcCtD
Levetiracetam—Dermatitis—Alendronate—osteoporosis	0.000295	0.000797	CcSEcCtD
Levetiracetam—Feeling abnormal—Pamidronate—osteoporosis	0.000294	0.000796	CcSEcCtD
Levetiracetam—Headache—Alendronate—osteoporosis	0.000293	0.000793	CcSEcCtD
Levetiracetam—Paraesthesia—Zoledronate—osteoporosis	0.000293	0.000792	CcSEcCtD
Levetiracetam—Vomiting—Raloxifene—osteoporosis	0.000293	0.000791	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Pamidronate—osteoporosis	0.000292	0.000789	CcSEcCtD
Levetiracetam—Rash—Raloxifene—osteoporosis	0.00029	0.000785	CcSEcCtD
Levetiracetam—Dermatitis—Raloxifene—osteoporosis	0.00029	0.000784	CcSEcCtD
Levetiracetam—Somnolence—Zoledronate—osteoporosis	0.00029	0.000784	CcSEcCtD
Levetiracetam—Vomiting—Ibandronate—osteoporosis	0.00029	0.000783	CcSEcCtD
Levetiracetam—Tremor—Estradiol—osteoporosis	0.000288	0.00078	CcSEcCtD
Levetiracetam—Headache—Raloxifene—osteoporosis	0.000288	0.00078	CcSEcCtD
Levetiracetam—Rash—Ibandronate—osteoporosis	0.000287	0.000777	CcSEcCtD
Levetiracetam—Dermatitis—Ibandronate—osteoporosis	0.000287	0.000776	CcSEcCtD
Levetiracetam—Dyspepsia—Zoledronate—osteoporosis	0.000287	0.000776	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000286	0.000774	CcSEcCtD
Levetiracetam—SV2A—Disease—ADCY5—osteoporosis	0.000285	0.00373	CbGpPWpGaD
Levetiracetam—Headache—Ibandronate—osteoporosis	0.000285	0.000772	CcSEcCtD
Levetiracetam—Insomnia—Conjugated Estrogens—osteoporosis	0.000284	0.000768	CcSEcCtD
Levetiracetam—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000284	0.000767	CcSEcCtD
Levetiracetam—Vomiting—Calcitriol—osteoporosis	0.000284	0.000767	CcSEcCtD
Levetiracetam—Decreased appetite—Zoledronate—osteoporosis	0.000283	0.000767	CcSEcCtD
Levetiracetam—Agitation—Estradiol—osteoporosis	0.000283	0.000765	CcSEcCtD
Levetiracetam—Nausea—Estropipate—osteoporosis	0.000282	0.000763	CcSEcCtD
Levetiracetam—Abdominal pain—Pamidronate—osteoporosis	0.000282	0.000763	CcSEcCtD
Levetiracetam—Body temperature increased—Pamidronate—osteoporosis	0.000282	0.000763	CcSEcCtD
Levetiracetam—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000282	0.000762	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000281	0.000761	CcSEcCtD
Levetiracetam—Rash—Calcitriol—osteoporosis	0.000281	0.000761	CcSEcCtD
Levetiracetam—Fatigue—Zoledronate—osteoporosis	0.000281	0.00076	CcSEcCtD
Levetiracetam—Dermatitis—Calcitriol—osteoporosis	0.000281	0.00076	CcSEcCtD
Levetiracetam—Headache—Calcitriol—osteoporosis	0.000279	0.000756	CcSEcCtD
Levetiracetam—Somnolence—Conjugated Estrogens—osteoporosis	0.000279	0.000755	CcSEcCtD
Levetiracetam—Constipation—Zoledronate—osteoporosis	0.000279	0.000754	CcSEcCtD
Levetiracetam—Pain—Zoledronate—osteoporosis	0.000279	0.000754	CcSEcCtD
Levetiracetam—Nausea—Alendronate—osteoporosis	0.000278	0.000752	CcSEcCtD
Levetiracetam—Hypersensitivity—Risedronate—osteoporosis	0.000277	0.000748	CcSEcCtD
Levetiracetam—Vertigo—Estradiol—osteoporosis	0.000277	0.000748	CcSEcCtD
Levetiracetam—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000276	0.000747	CcSEcCtD
Levetiracetam—Asthenia—Ethinyl Estradiol—osteoporosis	0.000276	0.000747	CcSEcCtD
Levetiracetam—Nausea—Raloxifene—osteoporosis	0.000273	0.000739	CcSEcCtD
Levetiracetam—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000273	0.000738	CcSEcCtD
Levetiracetam—Pruritus—Ethinyl Estradiol—osteoporosis	0.000272	0.000737	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000271	0.000733	CcSEcCtD
Levetiracetam—Fatigue—Conjugated Estrogens—osteoporosis	0.000271	0.000732	CcSEcCtD
Levetiracetam—Nausea—Ibandronate—osteoporosis	0.000271	0.000732	CcSEcCtD
Levetiracetam—Asthenia—Risedronate—osteoporosis	0.000269	0.000729	CcSEcCtD
Levetiracetam—Feeling abnormal—Zoledronate—osteoporosis	0.000269	0.000727	CcSEcCtD
Levetiracetam—Cough—Estradiol—osteoporosis	0.000269	0.000727	CcSEcCtD
Levetiracetam—Pain—Conjugated Estrogens—osteoporosis	0.000268	0.000726	CcSEcCtD
Levetiracetam—Constipation—Conjugated Estrogens—osteoporosis	0.000268	0.000726	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Zoledronate—osteoporosis	0.000267	0.000721	CcSEcCtD
Levetiracetam—Pruritus—Risedronate—osteoporosis	0.000266	0.000718	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—AGER—osteoporosis	0.000265	0.00347	CbGpPWpGaD
Levetiracetam—Nausea—Calcitriol—osteoporosis	0.000265	0.000716	CcSEcCtD
Levetiracetam—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000263	0.000713	CcSEcCtD
Levetiracetam—Hypersensitivity—Pamidronate—osteoporosis	0.000263	0.000711	CcSEcCtD
Levetiracetam—SV2A—Disease—MTHFR—osteoporosis	0.000263	0.00343	CbGpPWpGaD
Levetiracetam—Chest pain—Estradiol—osteoporosis	0.000262	0.000709	CcSEcCtD
Levetiracetam—Myalgia—Estradiol—osteoporosis	0.000262	0.000709	CcSEcCtD
Levetiracetam—Arthralgia—Estradiol—osteoporosis	0.000262	0.000709	CcSEcCtD
Levetiracetam—Anxiety—Estradiol—osteoporosis	0.000261	0.000706	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00026	0.000704	CcSEcCtD
Levetiracetam—Abdominal pain—Zoledronate—osteoporosis	0.000258	0.000697	CcSEcCtD
Levetiracetam—Body temperature increased—Zoledronate—osteoporosis	0.000258	0.000697	CcSEcCtD
Levetiracetam—Diarrhoea—Risedronate—osteoporosis	0.000257	0.000695	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000257	0.000694	CcSEcCtD
Levetiracetam—Asthenia—Pamidronate—osteoporosis	0.000256	0.000693	CcSEcCtD
Levetiracetam—Dizziness—Ethinyl Estradiol—osteoporosis	0.000255	0.000689	CcSEcCtD
Levetiracetam—Confusional state—Estradiol—osteoporosis	0.000253	0.000685	CcSEcCtD
Levetiracetam—Pruritus—Pamidronate—osteoporosis	0.000253	0.000683	CcSEcCtD
Levetiracetam—SV2A—Disease—IRS2—osteoporosis	0.00025	0.00327	CbGpPWpGaD
Levetiracetam—Infection—Estradiol—osteoporosis	0.00025	0.000675	CcSEcCtD
Levetiracetam—Dizziness—Risedronate—osteoporosis	0.000248	0.000672	CcSEcCtD
Levetiracetam—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000248	0.000671	CcSEcCtD
Levetiracetam—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000248	0.000671	CcSEcCtD
Levetiracetam—Nervous system disorder—Estradiol—osteoporosis	0.000246	0.000666	CcSEcCtD
Levetiracetam—Vomiting—Ethinyl Estradiol—osteoporosis	0.000245	0.000662	CcSEcCtD
Levetiracetam—Diarrhoea—Pamidronate—osteoporosis	0.000244	0.000661	CcSEcCtD
Levetiracetam—Skin disorder—Estradiol—osteoporosis	0.000244	0.00066	CcSEcCtD
Levetiracetam—Rash—Ethinyl Estradiol—osteoporosis	0.000243	0.000657	CcSEcCtD
Levetiracetam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000243	0.000656	CcSEcCtD
Levetiracetam—Headache—Ethinyl Estradiol—osteoporosis	0.000241	0.000652	CcSEcCtD
Levetiracetam—Hypersensitivity—Zoledronate—osteoporosis	0.00024	0.00065	CcSEcCtD
Levetiracetam—Vomiting—Risedronate—osteoporosis	0.000239	0.000646	CcSEcCtD
Levetiracetam—Rash—Risedronate—osteoporosis	0.000237	0.00064	CcSEcCtD
Levetiracetam—Dermatitis—Risedronate—osteoporosis	0.000237	0.00064	CcSEcCtD
Levetiracetam—Dizziness—Pamidronate—osteoporosis	0.000236	0.000638	CcSEcCtD
Levetiracetam—Headache—Risedronate—osteoporosis	0.000235	0.000636	CcSEcCtD
Levetiracetam—Asthenia—Zoledronate—osteoporosis	0.000234	0.000633	CcSEcCtD
Levetiracetam—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000231	0.000626	CcSEcCtD
Levetiracetam—Pruritus—Zoledronate—osteoporosis	0.000231	0.000624	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000229	0.000619	CcSEcCtD
Levetiracetam—Nausea—Ethinyl Estradiol—osteoporosis	0.000229	0.000619	CcSEcCtD
Levetiracetam—Insomnia—Estradiol—osteoporosis	0.000227	0.000615	CcSEcCtD
Levetiracetam—Vomiting—Pamidronate—osteoporosis	0.000227	0.000614	CcSEcCtD
Levetiracetam—Paraesthesia—Estradiol—osteoporosis	0.000226	0.00061	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000226	0.00295	CbGpPWpGaD
Levetiracetam—Asthenia—Conjugated Estrogens—osteoporosis	0.000225	0.000609	CcSEcCtD
Levetiracetam—Rash—Pamidronate—osteoporosis	0.000225	0.000609	CcSEcCtD
Levetiracetam—Dermatitis—Pamidronate—osteoporosis	0.000225	0.000608	CcSEcCtD
Levetiracetam—Headache—Pamidronate—osteoporosis	0.000224	0.000605	CcSEcCtD
Levetiracetam—Somnolence—Estradiol—osteoporosis	0.000223	0.000604	CcSEcCtD
Levetiracetam—Diarrhoea—Zoledronate—osteoporosis	0.000223	0.000603	CcSEcCtD
Levetiracetam—Nausea—Risedronate—osteoporosis	0.000223	0.000603	CcSEcCtD
Levetiracetam—Pruritus—Conjugated Estrogens—osteoporosis	0.000222	0.000601	CcSEcCtD
Levetiracetam—Dyspepsia—Estradiol—osteoporosis	0.000221	0.000598	CcSEcCtD
Levetiracetam—Decreased appetite—Estradiol—osteoporosis	0.000218	0.000591	CcSEcCtD
Levetiracetam—SV2A—Disease—IRS1—osteoporosis	0.000218	0.00285	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Estradiol—osteoporosis	0.000217	0.000587	CcSEcCtD
Levetiracetam—Fatigue—Estradiol—osteoporosis	0.000217	0.000586	CcSEcCtD
Levetiracetam—Dizziness—Zoledronate—osteoporosis	0.000216	0.000583	CcSEcCtD
Levetiracetam—Pain—Estradiol—osteoporosis	0.000215	0.000581	CcSEcCtD
Levetiracetam—Constipation—Estradiol—osteoporosis	0.000215	0.000581	CcSEcCtD
Levetiracetam—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000215	0.000581	CcSEcCtD
Levetiracetam—Nausea—Pamidronate—osteoporosis	0.000212	0.000573	CcSEcCtD
Levetiracetam—Dizziness—Conjugated Estrogens—osteoporosis	0.000208	0.000561	CcSEcCtD
Levetiracetam—Vomiting—Zoledronate—osteoporosis	0.000207	0.000561	CcSEcCtD
Levetiracetam—Feeling abnormal—Estradiol—osteoporosis	0.000207	0.00056	CcSEcCtD
Levetiracetam—Rash—Zoledronate—osteoporosis	0.000206	0.000556	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Estradiol—osteoporosis	0.000205	0.000556	CcSEcCtD
Levetiracetam—Dermatitis—Zoledronate—osteoporosis	0.000205	0.000555	CcSEcCtD
Levetiracetam—SV2A—Disease—IL6R—osteoporosis	0.000205	0.00268	CbGpPWpGaD
Levetiracetam—Headache—Zoledronate—osteoporosis	0.000204	0.000552	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000201	0.00263	CbGpPWpGaD
Levetiracetam—Vomiting—Conjugated Estrogens—osteoporosis	0.0002	0.00054	CcSEcCtD
Levetiracetam—Abdominal pain—Estradiol—osteoporosis	0.000199	0.000537	CcSEcCtD
Levetiracetam—Body temperature increased—Estradiol—osteoporosis	0.000199	0.000537	CcSEcCtD
Levetiracetam—Rash—Conjugated Estrogens—osteoporosis	0.000198	0.000535	CcSEcCtD
Levetiracetam—Dermatitis—Conjugated Estrogens—osteoporosis	0.000198	0.000535	CcSEcCtD
Levetiracetam—Headache—Conjugated Estrogens—osteoporosis	0.000197	0.000532	CcSEcCtD
Levetiracetam—Nausea—Zoledronate—osteoporosis	0.000194	0.000524	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00019	0.00248	CbGpPWpGaD
Levetiracetam—Nausea—Conjugated Estrogens—osteoporosis	0.000186	0.000504	CcSEcCtD
Levetiracetam—Hypersensitivity—Estradiol—osteoporosis	0.000185	0.000501	CcSEcCtD
Levetiracetam—Asthenia—Estradiol—osteoporosis	0.00018	0.000488	CcSEcCtD
Levetiracetam—Pruritus—Estradiol—osteoporosis	0.000178	0.000481	CcSEcCtD
Levetiracetam—Diarrhoea—Estradiol—osteoporosis	0.000172	0.000465	CcSEcCtD
Levetiracetam—Dizziness—Estradiol—osteoporosis	0.000166	0.000449	CcSEcCtD
Levetiracetam—Vomiting—Estradiol—osteoporosis	0.00016	0.000432	CcSEcCtD
Levetiracetam—Rash—Estradiol—osteoporosis	0.000158	0.000428	CcSEcCtD
Levetiracetam—Dermatitis—Estradiol—osteoporosis	0.000158	0.000428	CcSEcCtD
Levetiracetam—Headache—Estradiol—osteoporosis	0.000157	0.000426	CcSEcCtD
Levetiracetam—Nausea—Estradiol—osteoporosis	0.000149	0.000404	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000135	0.00177	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000127	0.00165	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MYC—osteoporosis	0.000121	0.00159	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—osteoporosis	0.000121	0.00158	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—osteoporosis	0.000112	0.00147	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—osteoporosis	0.000111	0.00145	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000106	0.00139	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—osteoporosis	9.12e-05	0.00119	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—osteoporosis	8.61e-05	0.00113	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.46e-05	0.00111	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	8.19e-05	0.00107	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—osteoporosis	8.04e-05	0.00105	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PKM—osteoporosis	7.56e-05	0.000989	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FDPS—osteoporosis	7.56e-05	0.000989	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPD2—osteoporosis	7.17e-05	0.000937	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PGLS—osteoporosis	7.17e-05	0.000937	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.09e-05	0.000927	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ATIC—osteoporosis	6.56e-05	0.000857	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PNP—osteoporosis	6.56e-05	0.000857	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—OXCT1—osteoporosis	5.57e-05	0.000729	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CA2—osteoporosis	5.57e-05	0.000729	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MGLL—osteoporosis	5.43e-05	0.00071	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—IDH2—osteoporosis	4.62e-05	0.000604	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP27A1—osteoporosis	4.34e-05	0.000568	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.26e-05	0.000557	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.25e-05	0.000556	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACP5—osteoporosis	4.22e-05	0.000552	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.98e-05	0.00052	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.97e-05	0.000519	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TPI1—osteoporosis	3.93e-05	0.000513	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—P4HB—osteoporosis	3.69e-05	0.000483	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GAPDH—osteoporosis	3.62e-05	0.000474	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—RAP1A—osteoporosis	3.53e-05	0.000462	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ENO1—osteoporosis	2.85e-05	0.000373	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PSMA2—osteoporosis	2.81e-05	0.000368	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PSMA5—osteoporosis	2.81e-05	0.000368	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP19A1—osteoporosis	2.28e-05	0.000298	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADCY5—osteoporosis	1.86e-05	0.000244	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX1—osteoporosis	1.86e-05	0.000243	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—osteoporosis	1.71e-05	0.000224	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—POMC—osteoporosis	1.37e-05	0.000179	CbGpPWpGaD
